期刊文献+

P-AKT在非小细胞肺癌中的表达及意义

Expressions and significance of P-AKT in non-small cell lung cancer
下载PDF
导出
摘要 目的研究P-AKT在非小细胞肺癌(non-small cell lung carcinoma,NSCLC)中的表达及意义,探讨其与NSCLC临床病理特征的关系,为NSCLC的诊断和治疗提供临床指导。方法采用免疫组织化学Maxvision二步法检测P-AKT在66例NSCLC和10例正常肺组织中的表达情况,采用SPSS13.0统计软件进行数据处理。结果 P-AKT在NSCLC中的阳性率为75.8%(50/66),在正常组织中的阳性率为20.0%(2/10),两组比较具有统计学意义(P<0.05)。在非小细胞肺癌中,P-AKT的过高表达与淋巴结转移、远处转移及分化程度密切相关(P<0.05)。结论 P-AKT在NSCLC中的表达显著高于正常肺组织,且与临床病理特征有相关性,表明P-AKT可能在NSCLC的发生发展中发挥着促进作用,检测该因子有助于判断NSCLC的恶性度以及为NSCLC的治疗提供治疗靶点。 Objective: To study the expressions and significance of P-AKT in non-small cell lung cancer,and explore the relationship of its and clinical pathologic features of non-small cell lung cancer,and to provide the clinical guidance for the diagnosis and treatment of non-small cell lung cancer.Methods: Immunohistochemistry Maxvision two-step method was used to examine the expressions of P-AKT in 66 cases of non-small cell lung cancer and 10 cases of normal lung tissue.Data were processed by SPSS version 13.0.Results: The positive expression rate of P-AKT was 75.8%(50/66) in non-small cell lung cancer,and 20.0%(2/10) in normal lung tissue,and the difference is significant in the statistics(P0.05).In the non-small cell lung cancer,the overexpression of P-AKT had significant correlation with the differentiation extent of cancer tissue,metastasis of lymph nodes and distance(P0.05).Conclusion: The expression of P-AKT in the non-small cell lung cancer is higher than that in the normal lung tissue,and it has significant correlation with the clinical pathologic features,which shows that P-AKT may play a role in promoting in the occurrence and development of non-small cell lung cancer.The detection of this factor is helpful to judge the malignant degree of NSCLC and provide therapeutic targets for treatment of NSCLC.
出处 《泰山医学院学报》 CAS 2013年第2期94-97,共4页 Journal of Taishan Medical College
关键词 非小细胞肺癌 P-AKT 免疫组织化学 non-small cell lung cancer P-AKT immunohistochemistry
  • 相关文献

参考文献10

二级参考文献88

  • 1沈丽佳,谢思明,殷操,阮萍,姚希.抑癌基因PTEN和FHIT在口腔鳞癌中的表达及其与cyclin D1的相关性[J].第一军医大学学报,2005,25(1):79-82. 被引量:14
  • 2An Q, Liu Y, Gao Y, et al. Deletion of tumor suppressor genes in Chinese non-small cell lung cancer. Cancer Lett, 2002;184:189~195.
  • 3Drevs J, Medinger M, Schmidt-Gersbach C, et al. Receptor tyrosine kinases: the main targets for new anticancer therapy. Curr Drug Targets,2003 ;4:113~121.
  • 4Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer,2002 ;2:489~501.
  • 5Brognard J, Clark AS, Ni Y, et al. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res, 2001; 61: 3986~3997.
  • 6Daveis MA, Koul D, Dhesi H, et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res, 1999 ;59: 2551~2556.
  • 7Hutchinson J, Jin J, Cardiff RD, et al. Activation of Akt ( protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol,2001 ;21:2203~2212.
  • 8Malik SN, Brattain M, Ghosh PM, et al. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res, 2002; 8: 1168~1171.
  • 9Freitas S, Moore DH, Michael H, et al. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance. Clin Cancer Res, 2003; 9:4689~4694.
  • 10Clark AS, West KA, Blumberg PM, et al. Altered portein kinase C (PKC) isoforms in non-small cell lung cancer cells:PKC delta promotes cellular survival and chemotherapeutic resistance. Cancer Res, 2003; 63: 780~786.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部